P-279Cetuximab as third line treatment of metastatic colorectal carcinoma (mCRC) – 5-year experience from the Institute of Oncology and Radiology of SerbiaJ. Spasic, N. Stanic, M. Ristic, F. Djordjevic, N. Nikolic, V. Nikolic, S. Pupovac, D. RadasavljevicAnnals of Oncology（2015）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
